59 results
DEFA14A
EX-10
BRKR
Bruker Corp
18 Apr 06
Additional proxy soliciting materials
12:00am
of appointment or resignation.
Section 2. Compensation and Expense Reimbursement. In return for his services as a member of the Special Committee, each … request to the Corporation, to payment or reimbursement by the Corporation, within ten (10) days of receipt of the request, of all reasonable
DEFA14A
EX-10.1
BRKR
Bruker Corp
3 Dec 07
Additional proxy soliciting materials
12:00am
. Compensation and Expense Reimbursement. In return for his services as a member of the Special Committee, each Director shall be entitled to receive from … or reimbursement by the Corporation, within ten (10) days of receipt of the request, of all reasonable expenses, including, without limitation, attorneys
8-K
EX-10
BRKR
Bruker Corp
18 Apr 06
Bruker BioSciences Corporation Announces Agreement to Acquire Bruker Optics Inc. for $135 Million in Cash and Stock
12:00am
of appointment or resignation.
Section 2. Compensation and Expense Reimbursement. In return for his services as a member of the Special Committee, each … request to the Corporation, to payment or reimbursement by the Corporation, within ten (10) days of receipt of the request, of all reasonable
8-K
EX-10.1
BRKR
Bruker Corp
3 Dec 07
Bruker BioSciences Corporation Announces Agreement to Acquire the Bruker BioSpin Group for $914 Million in Cash and Stock
12:00am
. Compensation and Expense Reimbursement. In return for his services as a member of the Special Committee, each Director shall be entitled to receive from … or reimbursement by the Corporation, within ten (10) days of receipt of the request, of all reasonable expenses, including, without limitation, attorneys
8-K
BRKR
Bruker Corp
16 Aug 05
Bruker AXS to Acquire X-Ray Analysis Software Company SOCABIM
12:00am
, copies of which were supplied to BAXS’ customers, and for which BAXS paid R&D reimbursement and per-copy transfer prices to SOCABIM.
At the closing, which
8-K
EX-10.1
d5gd8ynb
11 Feb 19
Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results
4:10pm
8-K
EX-10.1
olnme4g m35h5
27 Feb 08
Bruker Corporation Announces Closing of the Acquisition of the Bruker BioSpin Group
12:00am
8-K
EX-10.1
pvpgo66p9
25 May 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jt6e9g2pe2t iaed
12 Dec 19
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10
v34jvh6hd0zcqadamrv4
7 Jul 06
Bruker BioSciences Announces Closing of Acquisition of Bruker Optics
12:00am
8-K
EX-10.1
6tjf9nbos0c8 ig
18 Jan 24
Entry into a Material Definitive Agreement
8:29pm
S-1/A
EX-1.1
r6ut6v3qvd3oeav6j
30 May 00
IPO registration (amended)
12:00am
8-K
EX-99.1
r6knpzr
10 Aug 04
Results of Operations and Financial Condition
12:00am